European investment

The European Investment Bank (EIB) is the long-term lending institution of the European Union and one of the largest multi-lateral lenders in the world. While not a biotechnology company itself, the EIB is a critical pillar of the European life sciences ecosystem, providing significant venture debt and strategic financing to biotech, medtech, and pharmaceutical companies. Through its dedicated health and life sciences division, the bank supports the development of innovative therapies, vaccine manufacturing, and healthcare infrastructure across Europe. Its financing often bridges the 'valley of death' for mid-stage clinical companies, enabling them to scale operations and advance R&D without immediate equity dilution.